LAVA Therapeutics N.V. (LVTX) Misses Q3 EPS by 13c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.46), $0.13 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• VersaBank (VBNK) PT Lowered to $20 at Raymond James
• Victoria’s Secret shares slump 16% on weak Q3 operating income outlook